LOADING
Comparing Merck & Company (MRK) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | T |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $305.1B | $146.8B |
| P/E Ratio | 34.8 | 7.1 |
| Forward P/E | 24.4 | 9.2 |
| PEG Ratio | 6.10 | 1.48 |
| EPS | $3.55 | $2.97 |
| Revenue Growth (YoY) | 4.9% | 2.9% |
| Profit Margin | 13.6% | 16.9% |
| Return on Equity | 18.9% | 18.4% |
| Dividend Yield | 2.62% | 5.35% |
| Beta | 0.20 | 0.42 |
| 52-Week High | $130.29 | $28.75 |
| 52-Week Low | $74.18 | $19.63 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AT&T Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.